Recombinant Yersinia pestis lcrV Protein ，His & SUMO

LcrV, a key component of the Yersinia pestis type III secretion system, plays a pivotal role in the virulence of this notorious pathogen, which is the causative agent of plague. As a multifunctional protein, LcrV is involved in modulating host immune responses and affecting the bacterial ability to invade host cells. Research on LcrV has gained momentum due to its potential as a vaccine candidate and therapeutic target against Yersinia infections. Its immunogenic properties make it a subject of interest for designing subunit vaccines that could elicit protective immune responses. Additionally, understanding the structural dynamics and functional mechanisms of LcrV can provide insights into the broader context of type III secretion systems across various pathogens. Structural studies, including crystallography and cryo-electron microscopy, have elucidated the protein's conformation and interactions, offering valuable data for rational drug design. The ongoing research efforts on LcrV involve exploring its role in bacterial pathogenesis, its interactions with host proteins, and the development of recombinant forms for vaccine trials, emphasizing the importance of this protein in the fight against infectious diseases caused by Yersinia species. Such studies not only contribute to our understanding of bacterial pathogenicity but also pave the way for innovative strategies in vaccine development and therapeutic interventions.